GLP-1 safety trends and emerging side effects While gastrointestinal discomfort is the most common issue, new safety signals continue to emerge
A single dose of exenatide had no effect on blood flow velocity in the middle cerebral artery in elderly healthy volunteers: randomized, placebo-controlled, double-blind clinical trial
Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on
Empagliflozin Add-On Combination Therapy with Metformin HCl in Adult Patients with Type 2 Diabetes Mellitus A total of 637 patients with type 2 diabetes mellitus participated in a double-blind, placebo-controlled trial to evaluate the efficacy of empagliflozin in combination with metformin HCl
Market Inclusions This report covers global and regional market sizes for GLP1 receptor agonists over a defined forecast period, including drug classes (injectables, oral formulations), major therapeutic indications (type 2 diabetes, obesity), and distribution channels (hospitals, retail pharmacies, specialty clinics)
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
